Rare diseases
Investigational molecules
Locations
Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer
SpainStudy of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments
SpainStudy of Mosunetuzumab and Polatuzumab Vedotin Combination Treatment in Patients with B-Cell Non-Hodgkin Lymphoma
SpainStudy Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease
SpainStudy Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions
SpainStudy on the Safety and Effectiveness of Telisotuzumab Vedotin for Patients with Previously Treated c-Met Positive Non-Small Cell Lung Cancer
SpainStudy on the Effects of GSK4004280 and GSK4011499 in Adults with HIV Infections
SpainStudy of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer
SpainStudy of Naxitamab and Sargramostim for High-Risk Neuroblastoma in Patients with Refractory Bone or Bone Marrow Disease
SpainStudy on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk
SpainStudy on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
SpainStudy Comparing Aficamten and Metoprolol for Adults with Symptomatic Hypertrophic Cardiomyopathy
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
